ArticleCancer medicine2023

Clinical impact of tumour burden on the efficacy of PD-1/PD-L1 inhibitors plus chemotherapy in non-small-cell lung cancer.

Taichi Miyawaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.